LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences (OTC Bulletin Board: GLIF - News) announced today it has received a waiver from The N.I.R. Group, LLC (“N.I.R. Group”), a Roslyn, N.Y.-based hedge fund that allows Grant to pursue alternate financing to pay down, in whole or in part, an existing financing debt to N.I.R.
